Hypermarcas (OTCMKTS:HYPMY) Shares Gap Down – Here’s Why

Hypermarcas (OTCMKTS:HYPMY) gapped down prior to trading on Wednesday . The stock had previously closed at $4.85, but opened at $4.62. Hypermarcas shares last traded at $4.62, with a volume of 634 shares changing hands.

Hypermarcas Price Performance

The stock has a market cap of $3.02 billion, a PE ratio of 20.70 and a beta of 0.82. The company has a quick ratio of 0.80, a current ratio of 1.26 and a debt-to-equity ratio of 0.63. The company’s fifty day moving average is $4.35 and its 200 day moving average is $4.45.

Hypermarcas (OTCMKTS:HYPMY) last released its quarterly earnings data on Wednesday, November 12th. The company reported $0.13 earnings per share (EPS) for the quarter. The company had revenue of $408.83 million during the quarter. Hypermarcas had a net margin of 12.03% and a return on equity of 6.99%.

About Hypermarcas

Hypera SA operates as a pharmaceutical company in Brazil. It offers prescription products under the Adacne, Addera, apri, AmpliumG, please, Celestamine, Celestone, Celestone Soluspan, Cizax, deciprax, Derive C Micro, Micro Drift, Dermotil Fusid, Digedrat, diprogent, Diprosalic, Diprosone, diprospan, Emprol XR, Flow, Garasone, Halobex, Lipanon, moon, Lydian, macrodantin, Max Sulid, milgamma, Mioflex A, nesina, Novotram, oximax, peridal, Peridal Suspension, PredSim, Pressaliv, Quadriderm, Rizi, Rizi M, softalm, tacroz, tinodin, umma, and velunid brands.